resisttb
- Dec 1, 2021
- 1 min read

South Africa sets another example of success in beating tuberculosis

During the Union’s 52nd World Conference on Lung Health in late October, Doctors Without Borders (MSF) announced the results of TB-PRACTEAL, the first multi-country randomized controlled clinical trial to report on the efficacy and safety of a multidrug-resistant tuberculosis (MDR-TB) treatment. Time has shown that MDR-TB is a very difficult form of tuberculosis to treat, requiring multidrug therapies to be administered over a period of nine to 24 months. Read Here.

Recent Posts

See All

Updated WHO 6-Month MDR-TB Regimen

Attached below is the updated WHO guidelines which contains a revision of the 6-Month MDR-TB regimen for adults.

Possible new method identified to assess severity of TB infection

Researchers at Washington University School of Medicine in St. Louis have discovered a molecule in the lungs of tuberculosis (TB) patients that reflects the levels of TB-causing bacteria in the lungs,

Drug-resistant TB: Rollout of shorter regimen hits a snag in South Africa

The much-anticipated rollout of the shorter regimen to treat drug-resistant tuberculosis (TB) has failed to make inroads leaving patients stranded across the country. Having started in March last year